Net profit of Nectar Lifescience rose 449.02% to Rs 5.60 crore in the quarter ended September 2024 as against Rs 1.02 crore during the previous quarter ended September 2023. Sales rose 7.52% to Rs 427.88 crore in the quarter ended September 2024 as against Rs 397.96 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 427.88 | 397.96 | 8 |
| OPM % | 10.13 | 6.75 | - |
| PBDT | 24.21 | 16.95 | 43 |
| PBT | 8.67 | 1.64 | 429 |
| NP | 5.60 | 1.02 | 449 |